The Latest Breaking News from Tuberculosis

At The Union World Conference on Lung Health, optimism abounded as new drug regimens were presented that could cut treatment time for drug-resistant TB by up to two-thirds. These regimens, with 85-90% success rates, offer hope to those affected by MDR-TB, who often face long treatments and 14,000 pills. Funding…

Official records show that the English poet’s landlady alerted Rome’s authorities to the 25-year-old’s illness months before he died from tuberculosis

In a series of moves experts say signal a shift in how developing countries deal with pharmaceuticals, South Africa, Colombia and others have recently adopted a more combative approach towards drugmakers, pushing back on policies that deny treatment to millions of people with tuberculosis and HIV

KLE Society's Dr. Prabhakar Kore Basic Science Research Centre organised a National Seminar on “Defying the Unseen Foe: Understanding Anti-microbial Resistance” in Belagavi. President, Infection Control Academy, Hyderabad, Ranga Reddy Burri, Scientist-D, National Institute for Research in Tuberculosis, Chennai, Siva Kumar Shanmugam, Principal, Jawaharlal Nehru Medical College, N.S. Mahantashetti, Medical…

A promising new cancer treatment looks to be especially successful against tuberculosis (TB), one of the world's most fatal infectious diseases. Read further on Dynamite News:

The pandemic brought notable setbacks in the effort to eradicate tuberculosis, which is likely to regain its notorious title of deadliest infectious disease in 2023. But there are signs of progress.

Indonesia is still struggling to fight tuberculosis (TB), with the second-highest number of cases worldwide.

Tuberculosis is often seen as a threat of the past. But it remains a significant concern worldwide, with international travel spreading the disease.

Tuberculosis figures reported in the capital between April and June this year have reached the highest quarterly number since since 2017

Capital’s infection rate almost double any other region in England

A vaccine against tuberculosis has never been closer to reality. But development slowed due to corporate interests